Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Deep Learning-Based System for Automatic Melanoma Detection
220
Zitationen
2
Autoren
2019
Jahr
Abstract
Melanoma is the deadliest form of skin cancer. Distinguishing melanoma lesions from non-melanoma lesions has however been a challenging task. Many Computer Aided Diagnosis and Detection Systems have been developed in the past for this task. They have been limited in performance due to the complex visual characteristics of the skin lesion images which consists of inhomogeneous features and fuzzy boundaries. In this paper, we propose a deep learning-based method that overcomes these limitations for automatic melanoma lesion detection and segmentation. An enhanced encoder-decoder network with encoder and decoder sub-networks connected through a series of skip pathways which brings the semantic level of the encoder feature maps closer to that of the decoder feature maps is proposed for efficient learning and feature extraction. The system employs multi-stage and multi-scale approach and utilizes softmax classifier for pixel-wise classification of melanoma lesions. We devise a new method called Lesion-classifier that performs the classification of skin lesions into melanoma and non-melanoma based on results derived from pixel-wise classification. Our experiments on two well-established public benchmark skin lesion datasets, International Symposium on Biomedical Imaging(ISBI)2017 and Hospital Pedro Hispano (PH2), demonstrate that our method is more effective than some state-of-the-art methods. We achieved accuracy and dice coefficient of 95% and 92% on ISIC 2017 dataset and accuracy and dice coefficient of 95% and 93% on PH2 datasets.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.497 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.112 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.674 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.809 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.362 Zit.